V
Vipa Thanachartwet
Researcher at Mahidol University
Publications - 38
Citations - 729
Vipa Thanachartwet is an academic researcher from Mahidol University. The author has contributed to research in topics: Dengue fever & Malaria. The author has an hindex of 16, co-authored 36 publications receiving 599 citations.
Papers
More filters
Journal ArticleDOI
Accuracy of a Commercial IgM ELISA for the Diagnosis of Human Leptospirosis in Thailand
Varunee Desakorn,Vanaporn Wuthiekanun,Vipa Thanachartwet,Duangjai Sahassananda,Wirongrong Chierakul,Apichat Apiwattanaporn,Nicholas P. J. Day,Direk Limmathurotsakul,Sharon J. Peacock +8 more
TL;DR: The accuracy of IgM ELISA is limited in the setting, and a receiver operating characteristic curve was used to determine the optimal cutoff value.
Journal ArticleDOI
Identification of clinical factors associated with severe dengue among Thai adults: a prospective study
Vipa Thanachartwet,Nittha Oer-areemitr,Supat Chamnanchanunt,Duangjai Sahassananda,Akanitt Jittmittraphap,Plengsakoon Suwannakudt,Varunee Desakorn,Anan Wattanathum +7 more
TL;DR: This study identified several clinical factors independently associated with the development of severe d Dengue among hospitalized adults with dengue that can aid in the early recognition and prompt management of at-risk patients to reduce morbidity and mortality.
Journal ArticleDOI
Downregulation of plasma miR-451 and miR-16 in Plasmodium vivax infection.
Supat Chamnanchanunt,Chieri Kuroki,Varunee Desakorn,Mari Enomoto,Vipa Thanachartwet,Duangjai Sahassananda,Jetsumon Sattabongkot,Rachaneeporn Jenwithisuk,Suthat Fucharoen,Saovaros Svasti,Tsukuru Umemura,Tsukuru Umemura +11 more
TL;DR: Analysis of plasma miRNAs obtained from malaria patients and normal subjects suggests that plasma miR-451 and miR -16 are relevant biomarkers for malaria infection.
Journal ArticleDOI
Risk Factors for Multidrug-Resistant Tuberculosis among Patients with Pulmonary Tuberculosis at the Central Chest Institute of Thailand.
Charoen Chuchottaworn,Vipa Thanachartwet,Piamlarp Sangsayunh,Thu Zar Myint Than,Duangjai Sahassananda,Manoon Surabotsophon,Varunee Desakorn +6 more
TL;DR: Clinical factors and chest radiographic findings associated with MDR-TB among patients with pulmonary TB may help physicians to provide proper management of cases for prevention of the development and spread of M DR-TB in future.
Journal ArticleDOI
Safety and tolerability of elubaquine (bulaquine, CDRI 80/53) for treatment of Plasmodium vivax malaria in Thailand
Srivicha Krudsood,Polrat Wilairatana,Noppadon Tangpukdee,K Chalermrut,S Srivilairit,Vipa Thanachartwet,Sant Muangnoicharoen,Natthanej Luplertlop,Gary M. Brittenham,Sornchai Looareesuwan +9 more
TL;DR: Elubaquine, as anti-relapse therapy for P. vivax malaria, was as safe and well tolerated as primaquine and did not cause clinically significant hemolysis.